Fig 1.
Flowchart of the search strategy and study inclusion, in accordance with the PRISMA statement.
Table 1.
Patient demographics and study characteristics.
Fig 2.
Postoperative complications in patients with dTGCTs.
Table 2.
Follow-up, recurrences, time to recurrence and complications.
Fig 3.
Complications in patients with lTGCTs.
Fig 4.
Recurrences in patients with dTGCTs.
Fig 5.
Recurrences in patients with lTGCTs.
Fig 6.
Recurrences (n = 50/63) of diffuse tenosynovial giant cell tumors (dTGCTs), and recurrences (n = 11/13) of localized tenosynovial giant cell tumors (lTGCTs).